126 related articles for article (PubMed ID: 9221925)
1. Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):267-74. PubMed ID: 9221925
[TBL] [Abstract][Full Text] [Related]
2. Alpha2C-adrenoceptors mediate inhibition of forskolin-stimulated cAMP production in rat striatum.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Dec; 52(2):228-34. PubMed ID: 9495543
[TBL] [Abstract][Full Text] [Related]
3. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
[TBL] [Abstract][Full Text] [Related]
4. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
5. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor.
Hudson AL; Robinson ES; Lalies MD; Tyacke RJ; Jackson HC; Nutt DJ
J Auton Pharmacol; 1999 Dec; 19(6):311-20. PubMed ID: 10961736
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
8. Quantification of alpha2A and alpha2C adrenoceptors in the rat striatum and in different regions of the spinal cord.
Uhlén S; Lindblom J; Tiger G; Wikberg JE
Acta Physiol Scand; 1997 Aug; 160(4):407-12. PubMed ID: 9338523
[TBL] [Abstract][Full Text] [Related]
9. [3H]RX821002 (2-methoxyidazoxan) binds to alpha 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney.
Callado LF; Gabilondo AM; Meana JJ
Eur J Pharmacol; 1996 Dec; 316(2-3):359-68. PubMed ID: 8982708
[TBL] [Abstract][Full Text] [Related]
10. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.
Callado LF; Meana JJ; Grijalba B; Pazos A; Sastre M; García-Sevilla JA
J Neurochem; 1998 Mar; 70(3):1114-23. PubMed ID: 9489732
[TBL] [Abstract][Full Text] [Related]
11. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
12. Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
Callado LF; Meana JJ
Eur J Pharmacol; 1997 Jul; 332(1):109-12. PubMed ID: 9298931
[TBL] [Abstract][Full Text] [Related]
13. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry.
Holmberg M; Scheinin M; Kurose H; Miettinen R
Neuroscience; 1999; 93(4):1323-33. PubMed ID: 10501456
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
Callado LF; Gabilondo AM; Meana JJ
Life Sci; 1999; 64(25):2327-39. PubMed ID: 10374896
[TBL] [Abstract][Full Text] [Related]
16. α
Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
[TBL] [Abstract][Full Text] [Related]
17. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
Fagerholm V; Philipp M; Hein L; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(3):301-9. PubMed ID: 15336948
[TBL] [Abstract][Full Text] [Related]
18. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]